Author Correction: Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments
Sci Rep. 2021 Mar 3;11(1):5461.
doi: 10.1038/s41598-021-85177-7.
1 Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
2 Department of Neurology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju, Korea.
3 Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.
4 Neuroscience Center, Samsung Medical Center, Seoul, Korea.
5 Department of Neurology, Yuseong Geriatric Rehabilitation Hospital, Pohang, Korea.
6 Department of Neurology, Myoungji Hospital, Hanyang University, Goyangsi, Korea.
7 Pharmaceutical Diagnostics, GE Healthcare, Chalfont St Giles, UK.
8 Stem Cell and Regenerative Medicine Institute, Samsung Medical Center, Seoul, Korea.
9 Department of Nuclear Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea. shmoon0914@gmail.com.
10 Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. sw72.seo@samsung.com.
11 Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea. sw72.seo@samsung.com.
12 Neuroscience Center, Samsung Medical Center, Seoul, Korea. sw72.seo@samsung.com.
13 Samsung Alzheimer Research Center, Samsung Medical Center, Seoul, Korea. sw72.seo@samsung.com.
14 Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University School of Medicine, Suwon, Korea. sw72.seo@samsung.com.